Taken together with the strong TGFβ priming effects on TNF-induced osteoclastogenesis in vitro and in vivo, the different bone damage in RA and SLE is attributed, at least partially, to the differences in TGFβ levels or activity. Here, TGFB1 is linked to systemic lupus erythematosus.